Company Search:
Advanced Search
Sponsored Links
Onxeo SA Company Snapshot
Onxeo SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Onxeo SA with three other pharmaceutical manufacturers in Europe: Enzymatica AB (publ) of Sweden (2016 sales of 36.48 million Swedish Kronor [US$4.55 million] of which 100% was Medical Devices), Collagen Solutions PLC of the United Kingdom (£3.13 million [US$4.32 million] ), and Paion AG which is based in Germany (4.26 million Euro [US$5.22 million] of which 100% was Pharmaceutical).

Sales Analysis. Onxeo SA reported sales of 4.42 million Euro (US$5.42 million) for the year ending December of 2016. This represents an increase of 27.1% versus 2015, when the company's sales were 3.48 million Euro. Despite this increase, sales are still well below the level achieved in 2014, when Onxeo SA reported sales of 22.08 million Euro. Sales of Operating Segment -Rest of the World saw an increase of 37.8% in 2016, from 2.64 million Euro to 3.63 million Euro. Not all segments of Onxeo SA experienced an increase in sales in 2016: sales of Operating Segment - Europe fell 6.5% to 791,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Onxeo SA
  Stock Performance Chart for Onxeo SA
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.86
(Figures in Euro)
1 Week 16.5%   13 Weeks 79.2%  
4 Weeks 16.5%   52 Weeks -29.7%  
Onxeo SA Key Data:
  Ticker: ONXEO Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,423,000
(Year Ending Jan 2017).
Employees: 52
  Currency: Euro Market Cap: 94,206,389
  Fiscal Yr Ends: December Shares Outstanding: 50,539,908
  Share Type: Action Ordinaries Closely Held Shares: 5,661,532
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.